News from microbion A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 28, 2020, 06:00 ET Microbion Awarded up to $17.1 Million from CARB-X and the Cystic Fibrosis Foundation to Develop Inhaled Antimicrobial for Chronic Respiratory Infections in CF

Microbion Corporation of Bozeman, Montana today announced it has been awarded up to US$17.1 million from CARB-X and the Cystic Fibrosis Foundation to ...


May 27, 2020, 08:00 ET Microbion Corporation Announces Orphan Drug Designation Granted for Pravibismane Suspension for Inhalation by US FDA

Microbion Corporation of Bozeman, MT and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced that the US FDA has granted orphan...


Oct 28, 2019, 08:00 ET Microbion Corporation Announces Results from Randomized, Double Blind, Placebo-Controlled Phase 1b Trial of Pravibismane (MBN-101) for Treatment of Moderate to Severe Chronic Infected Diabetic Foot Ulcers

Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced results from a Phase 1b trial of its...


Oct 25, 2019, 08:00 ET Microbion Corporation Announces Generic Name for Lead Antimicrobial Compound: Pravibismane

Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced that the World Health Organization...


Apr 15, 2019, 08:00 ET Microbion Corporation to Present Data Highlighting Broad Spectrum Activity of BisEDT at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

Microbion Corporation today announced that the company will present data highlighting the broad-spectrum activity of its novel antimicrobial agent...